Mackenzie Tatananni

The big takeaways from IonQ, Quantinuum, and others are that the sector keeps growing and there’s a lot of market share up for grabs.

Three Pfizer insiders executed transactions directly on the heels of the drugmaker’s second-quarter earnings report.

J.P. Morgan resumes coverage of Sandisk stock while Citi doubles down on its bullish call on the heels of the storage provider’s investor day.

Just days after Quantinuum’s first earnings report as a public company, the quantum leader unveils a partnership with Taiwan’s Quanta Computer.

Pershing Square Capital Management exited its position in Hertz after the company announced an equity offering in June, the hedge fund says.

Infleqtion says it remains on track to deliver a ‘utility-scale’ quantum computer later this year.

BofA Securities lowered its rating as the ticket reseller grapples with persistent profitability.

The cryptocurrency exchange has grappled with a sharp decline in crypto prices and trading volume.

Quantinuum reports higher-than-expected revenue and issues an upbeat annual outlook.

Nebius stock surges after second-quarter numbers from the AI cloud infrastructure company beat expectations. Short pressure may be helping, too.

Two senior executives including Home Depot’s chief financial officer will oversee operations in CEO Ted Decker’s absence.

Bank of America, Morgan Stanley, and JPMorgan Chase have pledged billions to invest in critical infrastructure including AI hardware.

Riot Platforms, the Bitcoin miner-turned-data center operator, has struck a $9.1 billion compute supply deal with Anthropic, a source tells Barron’s.

Nvidia stock slipped Tuesday, extending losses from Monday’s session.

IBM and Together AI are building a cluster on IBM’s cloud that will power the start-up’s open-source model inference.

Cardinal Health reports mixed quarterly performance across its business segments as earnings get a lift from one-time tariff refunds.

Hims faces restructuring charges as it shifts its U.S. weight-loss business away from compounded GLP-1 medications.

Jefferies analyst Edison Lee believes Apple has scrapped its all-glass iPhone, citing supply chain checks.

The biotech says its cystic fibrosis drug candidate missed the mark in a Phase 2a trial, though the news could be a boon to shares of Vertex Pharmaceuticals.

New data show a single dose of AbCellera’s menopause treatment, ABCL635, reduces how often patients with menopause experience hot flashes.